๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation

โœ Scribed by G Ferretti; M Merli; S Ginanni Corradini; V Callejon; P Tanzilli; A Masini; S Ferretti; M Iappelli; M Rossi; D Rivanera; D Lilli; C Mancini; A Attili; P Berloco


Book ID
116929699
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
73 KB
Volume
36
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Intramuscular hepatitis B immune globuli
โœ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Prophylaxis against hepatitis B recurren
โœ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA

Liver transplantation for chronic hepati
โœ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam